Lv11
18 积分 2022-09-14 加入
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
1小时前
待确认
Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation
1天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1天前
已完结
miR-584-5p is a New Potential Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma
3天前
已完结
Taletrectinib in ROS1 + Non–Small Cell Lung Cancer: TRUST
3天前
已完结
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
5天前
已完结
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
5天前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
8天前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
8天前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
8天前
已完结
皖公网安备34019202002308
